nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—GRIN2C—nerve—leprosy	0.0654	0.126	CbGeAlD
Amantadine—GRIN2B—nerve—leprosy	0.0517	0.0994	CbGeAlD
Amantadine—GRIN2A—nerve—leprosy	0.0452	0.0869	CbGeAlD
Amantadine—DDC—nerve—leprosy	0.0422	0.0812	CbGeAlD
Amantadine—GRIN3B—testis—leprosy	0.0312	0.06	CbGeAlD
Amantadine—MAOB—nerve—leprosy	0.0217	0.0418	CbGeAlD
Amantadine—DRD2—nerve—leprosy	0.0183	0.0353	CbGeAlD
Amantadine—GRIN2D—tendon—leprosy	0.0168	0.0324	CbGeAlD
Amantadine—GRIN2C—testis—leprosy	0.015	0.0288	CbGeAlD
Amantadine—GRIN2C—nervous system—leprosy	0.0147	0.0283	CbGeAlD
Amantadine—GRIN2D—testis—leprosy	0.0139	0.0268	CbGeAlD
Amantadine—GRIN2D—nervous system—leprosy	0.0137	0.0263	CbGeAlD
Amantadine—Psychotic disorder—Dapsone—leprosy	0.0132	0.0276	CcSEcCtD
Amantadine—GRIN3A—testis—leprosy	0.0131	0.0252	CbGeAlD
Amantadine—GRIN3A—nervous system—leprosy	0.0129	0.0247	CbGeAlD
Amantadine—Stupor—Thalidomide—leprosy	0.0128	0.0267	CcSEcCtD
Amantadine—GRIN2A—tendon—leprosy	0.0125	0.0241	CbGeAlD
Amantadine—GRIN1—nervous system—leprosy	0.0122	0.0234	CbGeAlD
Amantadine—GRIN2B—nervous system—leprosy	0.0116	0.0224	CbGeAlD
Amantadine—Photosensitivity reaction—Dapsone—leprosy	0.0107	0.0223	CcSEcCtD
Amantadine—GRIN2A—testis—leprosy	0.0104	0.0199	CbGeAlD
Amantadine—GRIN2A—nervous system—leprosy	0.0102	0.0195	CbGeAlD
Amantadine—Leukocytosis—Thalidomide—leprosy	0.0102	0.0212	CcSEcCtD
Amantadine—Dyskinesia—Thalidomide—leprosy	0.0102	0.0212	CcSEcCtD
Amantadine—Gait disturbance—Thalidomide—leprosy	0.00979	0.0204	CcSEcCtD
Amantadine—DDC—testis—leprosy	0.00968	0.0186	CbGeAlD
Amantadine—DDC—nervous system—leprosy	0.0095	0.0183	CbGeAlD
Amantadine—SIGMAR1—eye—leprosy	0.00949	0.0182	CbGeAlD
Amantadine—Depressed level of consciousness—Thalidomide—leprosy	0.00923	0.0192	CcSEcCtD
Amantadine—Lightheadedness—Thalidomide—leprosy	0.00855	0.0178	CcSEcCtD
Amantadine—Pulmonary oedema—Thalidomide—leprosy	0.0085	0.0177	CcSEcCtD
Amantadine—Hypertonia—Thalidomide—leprosy	0.00838	0.0175	CcSEcCtD
Amantadine—Hyperkinesia—Thalidomide—leprosy	0.00833	0.0174	CcSEcCtD
Amantadine—Mental disability—Thalidomide—leprosy	0.00829	0.0173	CcSEcCtD
Amantadine—Euphoric mood—Thalidomide—leprosy	0.00821	0.0171	CcSEcCtD
Amantadine—Photosensitivity—Thalidomide—leprosy	0.0079	0.0165	CcSEcCtD
Amantadine—Eczema—Thalidomide—leprosy	0.00772	0.0161	CcSEcCtD
Amantadine—Vision blurred—Dapsone—leprosy	0.00769	0.016	CcSEcCtD
Amantadine—DRD2—eye—leprosy	0.00766	0.0147	CbGeAlD
Amantadine—Cardiac failure congestive—Thalidomide—leprosy	0.00765	0.0159	CcSEcCtD
Amantadine—Renal failure acute—Thalidomide—leprosy	0.00751	0.0157	CcSEcCtD
Amantadine—Libido decreased—Thalidomide—leprosy	0.00748	0.0156	CcSEcCtD
Amantadine—Amnesia—Thalidomide—leprosy	0.00738	0.0154	CcSEcCtD
Amantadine—Visual disturbance—Thalidomide—leprosy	0.00732	0.0153	CcSEcCtD
Amantadine—Cardiac failure—Thalidomide—leprosy	0.00711	0.0148	CcSEcCtD
Amantadine—Lethargy—Thalidomide—leprosy	0.00708	0.0148	CcSEcCtD
Amantadine—Osteoarthritis—Thalidomide—leprosy	0.00694	0.0145	CcSEcCtD
Amantadine—Disturbance in sexual arousal—Thalidomide—leprosy	0.00688	0.0143	CcSEcCtD
Amantadine—Psychotic disorder—Thalidomide—leprosy	0.00677	0.0141	CcSEcCtD
Amantadine—Cardiac arrest—Thalidomide—leprosy	0.0066	0.0137	CcSEcCtD
Amantadine—Ataxia—Thalidomide—leprosy	0.00652	0.0136	CcSEcCtD
Amantadine—Tachycardia—Dapsone—leprosy	0.0065	0.0135	CcSEcCtD
Amantadine—Liver function test abnormal—Thalidomide—leprosy	0.0064	0.0133	CcSEcCtD
Amantadine—Orthostatic hypotension—Thalidomide—leprosy	0.00633	0.0132	CcSEcCtD
Amantadine—SIGMAR1—tendon—leprosy	0.00628	0.0121	CbGeAlD
Amantadine—ABCB1—blood vessel—leprosy	0.00622	0.012	CbGeAlD
Amantadine—Insomnia—Dapsone—leprosy	0.00602	0.0126	CcSEcCtD
Amantadine—MAOB—tendon—leprosy	0.00601	0.0116	CbGeAlD
Amantadine—Dysphagia—Thalidomide—leprosy	0.00599	0.0125	CcSEcCtD
Amantadine—Neutropenia—Thalidomide—leprosy	0.00561	0.0117	CcSEcCtD
Amantadine—SLC22A1—nervous system—leprosy	0.00553	0.0106	CbGeAlD
Amantadine—Photosensitivity reaction—Thalidomide—leprosy	0.00547	0.0114	CcSEcCtD
Amantadine—Body temperature increased—Dapsone—leprosy	0.00526	0.011	CcSEcCtD
Amantadine—SIGMAR1—testis—leprosy	0.0052	0.01	CbGeAlD
Amantadine—Agranulocytosis—Thalidomide—leprosy	0.00499	0.0104	CcSEcCtD
Amantadine—MAOB—testis—leprosy	0.00498	0.00957	CbGeAlD
Amantadine—MAOB—nervous system—leprosy	0.00489	0.0094	CbGeAlD
Amantadine—Urinary tract disorder—Thalidomide—leprosy	0.00474	0.00988	CcSEcCtD
Amantadine—Oedema peripheral—Thalidomide—leprosy	0.00473	0.00985	CcSEcCtD
Amantadine—Urethral disorder—Thalidomide—leprosy	0.0047	0.0098	CcSEcCtD
Amantadine—Visual impairment—Thalidomide—leprosy	0.00462	0.00964	CcSEcCtD
Amantadine—Eye disorder—Thalidomide—leprosy	0.00448	0.00935	CcSEcCtD
Amantadine—Cardiac disorder—Thalidomide—leprosy	0.00445	0.00928	CcSEcCtD
Amantadine—Angiopathy—Thalidomide—leprosy	0.00435	0.00907	CcSEcCtD
Amantadine—Mediastinal disorder—Thalidomide—leprosy	0.00432	0.00901	CcSEcCtD
Amantadine—Arrhythmia—Thalidomide—leprosy	0.00429	0.00893	CcSEcCtD
Amantadine—Alopecia—Thalidomide—leprosy	0.00424	0.00884	CcSEcCtD
Amantadine—Vomiting—Dapsone—leprosy	0.00423	0.00883	CcSEcCtD
Amantadine—Mental disorder—Thalidomide—leprosy	0.0042	0.00876	CcSEcCtD
Amantadine—DRD2—testis—leprosy	0.0042	0.00808	CbGeAlD
Amantadine—Malnutrition—Thalidomide—leprosy	0.00418	0.00871	CcSEcCtD
Amantadine—Headache—Dapsone—leprosy	0.00417	0.0087	CcSEcCtD
Amantadine—DRD2—nervous system—leprosy	0.00412	0.00793	CbGeAlD
Amantadine—Tension—Thalidomide—leprosy	0.0041	0.00854	CcSEcCtD
Amantadine—Nervousness—Thalidomide—leprosy	0.00406	0.00846	CcSEcCtD
Amantadine—Nausea—Dapsone—leprosy	0.00396	0.00824	CcSEcCtD
Amantadine—Vision blurred—Thalidomide—leprosy	0.00394	0.0082	CcSEcCtD
Amantadine—Tremor—Thalidomide—leprosy	0.00391	0.00816	CcSEcCtD
Amantadine—Agitation—Thalidomide—leprosy	0.00384	0.008	CcSEcCtD
Amantadine—Leukopenia—Thalidomide—leprosy	0.00374	0.00779	CcSEcCtD
Amantadine—Palpitations—Thalidomide—leprosy	0.00369	0.00769	CcSEcCtD
Amantadine—Convulsion—Thalidomide—leprosy	0.00362	0.00754	CcSEcCtD
Amantadine—Hypertension—Thalidomide—leprosy	0.00361	0.00752	CcSEcCtD
Amantadine—Anxiety—Thalidomide—leprosy	0.00354	0.00739	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00353	0.00736	CcSEcCtD
Amantadine—Dry mouth—Thalidomide—leprosy	0.00348	0.00725	CcSEcCtD
Amantadine—Confusional state—Thalidomide—leprosy	0.00344	0.00716	CcSEcCtD
Amantadine—Oedema—Thalidomide—leprosy	0.00341	0.00711	CcSEcCtD
Amantadine—Nervous system disorder—Thalidomide—leprosy	0.00334	0.00697	CcSEcCtD
Amantadine—Tachycardia—Thalidomide—leprosy	0.00333	0.00693	CcSEcCtD
Amantadine—Skin disorder—Thalidomide—leprosy	0.00331	0.0069	CcSEcCtD
Amantadine—Hyperhidrosis—Thalidomide—leprosy	0.0033	0.00687	CcSEcCtD
Amantadine—Anorexia—Thalidomide—leprosy	0.00325	0.00677	CcSEcCtD
Amantadine—Hypotension—Thalidomide—leprosy	0.00319	0.00664	CcSEcCtD
Amantadine—Insomnia—Thalidomide—leprosy	0.00308	0.00643	CcSEcCtD
Amantadine—Paraesthesia—Thalidomide—leprosy	0.00306	0.00638	CcSEcCtD
Amantadine—Dyspnoea—Thalidomide—leprosy	0.00304	0.00633	CcSEcCtD
Amantadine—Somnolence—Thalidomide—leprosy	0.00303	0.00632	CcSEcCtD
Amantadine—Dyspepsia—Thalidomide—leprosy	0.003	0.00625	CcSEcCtD
Amantadine—Decreased appetite—Thalidomide—leprosy	0.00296	0.00618	CcSEcCtD
Amantadine—Gastrointestinal disorder—Thalidomide—leprosy	0.00294	0.00613	CcSEcCtD
Amantadine—Fatigue—Thalidomide—leprosy	0.00294	0.00613	CcSEcCtD
Amantadine—Constipation—Thalidomide—leprosy	0.00292	0.00608	CcSEcCtD
Amantadine—Feeling abnormal—Thalidomide—leprosy	0.00281	0.00586	CcSEcCtD
Amantadine—Body temperature increased—Thalidomide—leprosy	0.00269	0.00562	CcSEcCtD
Amantadine—Hypersensitivity—Thalidomide—leprosy	0.00251	0.00523	CcSEcCtD
Amantadine—Asthenia—Thalidomide—leprosy	0.00245	0.0051	CcSEcCtD
Amantadine—Pruritus—Thalidomide—leprosy	0.00241	0.00503	CcSEcCtD
Amantadine—Diarrhoea—Thalidomide—leprosy	0.00233	0.00486	CcSEcCtD
Amantadine—Dizziness—Thalidomide—leprosy	0.00225	0.0047	CcSEcCtD
Amantadine—Vomiting—Thalidomide—leprosy	0.00217	0.00452	CcSEcCtD
Amantadine—Rash—Thalidomide—leprosy	0.00215	0.00448	CcSEcCtD
Amantadine—Dermatitis—Thalidomide—leprosy	0.00215	0.00448	CcSEcCtD
Amantadine—Headache—Thalidomide—leprosy	0.00214	0.00445	CcSEcCtD
Amantadine—Nausea—Thalidomide—leprosy	0.00202	0.00422	CcSEcCtD
Amantadine—ABCB1—testis—leprosy	0.00182	0.00349	CbGeAlD
Amantadine—ABCB1—nervous system—leprosy	0.00178	0.00343	CbGeAlD
